日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

Botensilimab(Fc增强型抗细胞毒性淋巴细胞相关蛋白-4抗体)联合Balstilimab(抗PD-1抗体)治疗复发/难治性转移性肉瘤患者

Wilky, Breelyn A; Schwartz, Gary K; Gordon, Michael S; El-Khoueiry, Anthony B; Bullock, Andrea J; Henick, Brian; Agulnik, Mark; Singh, Arun; Mahadevan, Daruka; Stebbing, Justin; Delepine, Chloe; Chand, Dhan; Avagyan, Manushak; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven; Trent, Jonathan C; Jones, Robin L; Tsimberidou, Apostolia M

Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer

在难治性卵巢癌患者中,Botensilimab(Fc增强型抗CTLA-4抗体)联合balstilimab(抗PD-1抗体)治疗方案

Porter, Rebecca; Bockorny, Bruno; Corr, Bradley R; Mahadevan, Daruka; Wilky, Breelyn A; El-Khoueiry, Anthony B; Bullock, Andrea J; Hafez, Navid; Moser, Justin; Martynova, Anastasia; Stebbing, Justin; Joshi, Bishnu; Bourdelais, Sean; Delepine, Chloe; Chand, Dhan; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven J; Matulonis, Ursula A; Gordon, Michael S

Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor

对接受过大量预处理的生殖细胞肿瘤进行异基因不变自然杀伤细胞挽救治疗

Garmezy, Benjamin; Grossman, Joseph E; Buell, Jennifer; Favano, Thiago; Stebbing, Justin; O'Day, Steven; Purbhoo, Marco A; Chand, Dhan; Greco, F Anthony

Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference

放射疗法联合免疫疗法的最新进展:第八届年度 ImmunoRad 会议论文集

Talebi, Fereshteh; Gregucci, Fabiana; Ahmed, Jalal; Ben Chetrit, Nir; D Brown, Brian; Chan, Timothy A; Chand, Dhan; Constanzo, Julie; Demaria, Sandra; I Gabrilovich, Dmitry; Golden, Encouse; Godkin, Andrew; Guha, Chandan; P Gupta, Gaorav; Hasan, Aisha; G Herrera, Fernanda; Kaufman, Howard; Li, Donna; A Melcher, Alan; McDonald, Sierra; Merghoub, Taha; Monjazeb, Arta M; Paris, Sébastien; Pitroda, Sean; Sadanandam, Anguraj; Schaue, Dörthe; Santambrogio, Laura; Szapary, Phillippe; Sage, Julien; W Welsh, James; Wilkins, Anna; H Young, Kristina; Wennerberg, Eric; Zitvogel, Laurence; Galluzzi, Lorenzo; Deutsch, Eric; C Formenti, Silvia

CAR-iNKT cells: redefining the frontiers of cellular immunotherapy

CAR-iNKT细胞:重新定义细胞免疫疗法的前沿

Niedzielska, Magdalena; Chalmers, Amy; Popis, Martyna C; Altman-Sharoni, Efrat; Addis, Stephen; Beulen, Rebekka; Rudqvist, Nils-Petter; Chantzoura, Eleni; Purbhoo, Marco A; Chand, Dhan; Exley, Mark A

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial

Botensilimab联合balstilimab治疗复发/难治性微卫星稳定型转移性结直肠癌:一项I期试验

Bullock, Andrea J; Schlechter, Benjamin L; Fakih, Marwan G; Tsimberidou, Apostolia M; Grossman, Joseph E; Gordon, Michael S; Wilky, Breelyn A; Pimentel, Agustin; Mahadevan, Daruka; Balmanoukian, Ani S; Sanborn, Rachel E; Schwartz, Gary K; Abou-Alfa, Ghassan K; Segal, Neil H; Bockorny, Bruno; Moser, Justin C; Sharma, Sunil; Patel, Jaymin M; Wu, Wei; Chand, Dhan; Rosenthal, Katherine; Mednick, Gabriel; Delepine, Chloe; Curiel, Tyler J; Stebbing, Justin; Lenz, Heinz-Josef; O'Day, Steven J; El-Khoueiry, Anthony B

Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Botensilimab 是一种 Fc 增强型抗 CTLA-4 抗体,对传统免疫疗法反应不佳的肿瘤有效

Chand Dhan, Savitsky David A, Krishnan Shanmugarajan, Mednick Gabriel, Delepine Chloe, Garcia-Broncano Pilar, Soh Kah Teong, Wu Wei, Wilkens Margaret K, Udartseva Olga, Vincent Sylvia, Joshi Bishnu, Keith Justin G, Manrique Mariana, Marques Marilyn, Tanne Antoine, Levey Daniel L, Han Haiyong, Ng Serina, Ridpath Jackson, Huber Olivia, Morin Benjamin, Galand Claire, Bourdelais Sean, Gombos Randi B, Ward Rebecca, Qin Yu, Waight Jeremy D, Costa Matthew R, Sebastian-Yague Alvaro, Rudqvist Nils-Petter, Pupecka-Swider Malgorzata, Venkatraman Vignesh, Slee Andrew, Patel Jaymin M, Grossman Joseph E, Wilson Nicholas S, Von Hoff Daniel D, Stebbing Justin, Curiel Tyler J, Buell Jennifer S, O'Day Steven J, Stein Robert B

Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas

Fc增强的抗CTLA-4、抗PD-1、阿霉素和超声介导的血脑屏障开放:一种治疗胶质瘤的新型联合免疫疗法方案

Kim, Kwang-Soo; Habashy, Karl; Gould, Andrew; Zhao, Junfei; Najem, Hinda; Amidei, Christina; Saganty, Ruth; Arrieta, Víctor A; Dmello, Crismita; Chen, Li; Zhang, Daniel Y; Castro, Brandyn; Billingham, Leah; Levey, Daniel; Huber, Olivia; Marques, Marilyn; Savitsky, David A; Morin, Benjamin M; Muzzio, Miguel; Canney, Michael; Horbinski, Craig; Zhang, Peng; Miska, Jason; Padney, Surya; Zhang, Bin; Rabadan, Raul; Phillips, Joanna J; Butowski, Nicholas; Heimberger, Amy B; Hu, Jian; Stupp, Roger; Chand, Dhan; Lee-Chang, Catalina; Sonabend, Adam M

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment

胶质母细胞瘤的免疫检查点阻断:从肿瘤异质性到个体化治疗

Arrieta, Víctor A; Dmello, Crismita; McGrail, Daniel J; Brat, Daniel J; Lee-Chang, Catalina; Heimberger, Amy B; Chand, Dhan; Stupp, Roger; Sonabend, Adam M

Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapy

新一代CTLA-4靶向分子和联合疗法:改善癌症免疫治疗的有效策略

Rudqvist, Nils-Petter; Avagyan, Manushak; Chand, Dhan